Oncology

Hormone receptor testing may be unnecessary in breast cancer patients.

Mechanism behind novel BRAF inhibitor resistance among patients with melanoma discovered.

Aromatase inhibitors in human estrogen-receptor positive breast cancer can cause tumor mutations.

Research identifies which melanoma patients will respond to immunotherapy drugs.

Pfizer and Medivation believe the merger could revolutionize cancer care.

Obesity becoming a growing health concern for cancer survivors, specifically breast and colorectal cancers.

Increased genetic knowledge about non-whites could lead to improved knowledge and treatments.

Protein inhibition shows promising reducing lung cancer progression.

Accumulation of chemicals found in drinking water supplied to 6 million people could lead to cancer and other health problems.

Caucasians found to have better skin cancer survival rates.

Top news of the day from across the health care landscape.

Top news of the week in oncology, and cancer drug development.

Blocking the migration path of cancer cells in the blood could create new, effective treatments for cancers, such as lymphoma.

Discovery may help tumor suppression on a molecular level.

Advance in lung cancer therapy achieved on molecular level.

Bacterial differences were seen between tissue from patients with and without breast cancer.

Caregivers need to encourage patients fearful of life-saving tests for cancer.

Researchers plan to create an extensive cancer screening test that detects cancer blood biomarkers.

Drug to be evaluated combination with letrozole for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer.

Ribociclib seeking indication for use in combination with letrozole for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer.

The FDA has granted breakthrough therapy designation to Novartis's ribociclib (LEE011).

Group of molecules may present target to slow tumor growth in prostate cancer.

Top news of the day from across the health care landscape.

Combination antibody therapy may lead to new melanoma treatment strategy.

Through physical evaluation, biphenotypic primary liver carcinoma could be misclassified.

The company will conduct a non-small cell lung cancer clinical trial with CV301 plus Opdivo.

Mutant KRAS gene may lead to new therapies for lung cancer.

Early treatment of ovarian cancer is vital to survival.